Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sung Lee Insider Profile
4 Followers
Sung Lee, EVP & CFO at Sangamo Biosciences, holds 100.49K shares in Vir Biotechnology (Ticker: VIR), holds 88.71K shares in Sangamo Biosciences (Ticker: SGMO). Most recently, Sung Lee Sold ― shares of Vir Biotechnology on Mar 28, 2024 for an estimated value of 59.36K.
Sung Lee has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sung Lee holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sung Lee
Sung Lee's Trading History
Sangamo Biosciences
Nov 30, 2020
EVP & CFO
Uninformative Sell
49.26K
$45.86K
Vir Biotechnology
Mar 28, 2024
EVP & CFO
Informative Sell
59.36K
$827.05K
List of latest transactions for each holding click on a transaction to see Sung Lee's performance on stock
You May Also Like
Sung Lee insider profile FAQ
What is the percentage of profitable transactions made by Sung Lee?
The percentage of profitable transactions made by Sung Lee is ―.
What is the average return per transaction made by Sung Lee?
The average return per transaction made by Sung Lee is ―.
What stocks does Sung Lee hold?
Sung Lee holds: SGMO, VIR stocks.
What was Sung Lee’s latest transaction?
Sung Lee latest transaction was an Informative Sell of $59.36K.
What was Sung Lee's most profitable transaction?
Sung Lee’s most profitable transaction was an Informative Sell of VIR stock on March 28, 2024. The return on the trade was 21.50%.
What is Sung Lee's role in Sangamo Biosciences?
Sung Lee's role in Sangamo Biosciences is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.